Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,366 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Balance and Gait Improvements of Postoperative Rehabilitation in Patients with Parkinson's Disease Treated with Subthalamic Nucleus Deep Brain Stimulation (STN-DBS).
Sato K, Aita N, Hokari Y, Kitahara E, Tani M, Izawa N, Hatori K, Nakamura R, Sasaki F, Sekimoto S, Jo T, Oyama G, Hatano T, Shimo Y, Iwamuro H, Umemura A, Hattori N, Fujiwara T. Sato K, et al. Among authors: tani m. Parkinsons Dis. 2019 Aug 4;2019:7104071. doi: 10.1155/2019/7104071. eCollection 2019. Parkinsons Dis. 2019. PMID: 31467660 Free PMC article.
New Artificial Intelligence-Integrated Electromyography-Driven Robot Hand for Upper Extremity Rehabilitation of Patients With Stroke: A Randomized, Controlled Trial.
Murakami Y, Honaga K, Kono H, Haruyama K, Yamaguchi T, Tani M, Isayama R, Takakura T, Tanuma A, Hatori K, Wada F, Fujiwara T. Murakami Y, et al. Among authors: tani m. Neurorehabil Neural Repair. 2023 May;37(5):298-306. doi: 10.1177/15459683231166939. Epub 2023 Apr 11. Neurorehabil Neural Repair. 2023. PMID: 37039319 Clinical Trial.
Factor analysis for construct validity of a trunk impairment scale in Parkinson's disease: a cross-sectional study.
Sato K, Yamazaki Y, Kameyama Y, Watanabe K, Kitahara E, Haruyama K, Takahashi Y, Fujino Y, Yamaguchi T, Matsuda T, Makabe H, Isayama R, Murakami Y, Tani M, Honaga K, Hatori K, Oji Y, Tomizawa Y, Hatano T, Hattori N, Fujiwara T. Sato K, et al. Among authors: tani m. Front Neurol. 2024 Jan 3;14:1303215. doi: 10.3389/fneur.2023.1303215. eCollection 2023. Front Neurol. 2024. PMID: 38234977 Free PMC article.
Efficacy and safety of intradialytic parenteral nutrition using ENEFLUID® in malnourished patients receiving maintenance hemodialysis: An exploratory, multicenter, randomized, open-label study.
Kabasawa H, Hosojima M, Kanda E, Nagai M, Murayama T, Tani M, Kamoshita S, Kuroda A, Kanno Y. Kabasawa H, et al. Among authors: tani m. PLoS One. 2024 Dec 12;19(12):e0311671. doi: 10.1371/journal.pone.0311671. eCollection 2024. PLoS One. 2024. PMID: 39666754 Free PMC article. Clinical Trial.
Zanubrutinib Versus Bendamustine and Rituximab in Patients With Treatment-Naïve Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: Median 5-Year Follow-Up of SEQUOIA.
Shadman M, Munir T, Robak T, Brown JR, Kahl BS, Ghia P, Giannopoulos K, Šimkovič M, Österborg A, Laurenti L, Walker PA, Opat SS, Ciepluch H, Greil R, Hanna M, Tani M, Trněný M, Brander D, Flinn IW, Grosicki S, Verner E, Tedeschi A, de Guibert S, Tumyan G, Laribi K, García-Marco JA, Li JY, Tian T, Liu Y, Korolkiewicz R, Szeto A, Tam CS, Jurczak W. Shadman M, et al. Among authors: tani m. J Clin Oncol. 2024 Dec 8:JCO2402265. doi: 10.1200/JCO-24-02265. Online ahead of print. J Clin Oncol. 2024. PMID: 39647999
Corrigendum to "Safety and efficacy of odronextamab in patients with relapsed or refractory follicular lymphoma": [Ann Oncol 35 (2024) 1039-1047].
Kim TM, Taszner M, Novelli S, Cho SG, Villasboas JC, Merli M, Jiménez-Ubieto A, Tessoulin B, Poon LM, Tucker D, Walewski J, Yi S, Song Y, Chong G, Bachy E, Guidez S, Alonso A, Jagadeesh D, Zhang W, Magnano L, Iskierka-Jażdżwska E, Tani M, Shen B, Uppala A, Zhu M, Shariff S, Brouwer-Visser J, Chaudhry A, Mohamed H, Ambati S, Luminari S; ELM-2 Investigators. Kim TM, et al. Among authors: tani m. Ann Oncol. 2024 Dec 2:S0923-7534(24)04945-7. doi: 10.1016/j.annonc.2024.11.009. Online ahead of print. Ann Oncol. 2024. PMID: 39627085 Free article. No abstract available.
Fibroblast Activation Protein-α Expression in Cancer-Associated Fibroblasts Shows the Poor Survival of Colorectal Cancer via Immune-Mediated Pathways : Implications of FAP in Cancer-Associated Fibroblasts Link Immune Dysregulation to Adverse Survival in Colorectal Cancer.
Qin Y, Miyake T, Muramoto K, Maekawa T, Nishina Y, Wang Y, Shimizu T, Tani M. Qin Y, et al. Among authors: tani m. Ann Surg Oncol. 2024 Dec 2. doi: 10.1245/s10434-024-16593-y. Online ahead of print. Ann Surg Oncol. 2024. PMID: 39623187
Selection of anti-cytokine biologics by pretreatment levels of serum leucine-rich alpha-2 glycoprotein in patients with inflammatory bowel disease.
Amano T, Yoshihara T, Shinzaki S, Sakakibara Y, Yamada T, Osugi N, Hiyama S, Murayama Y, Nagaike K, Ogiyama H, Yamaguchi T, Arimoto Y, Kobayashi I, Kawai S, Egawa S, Kizu T, Komori M, Tsujii Y, Asakura A, Tashiro T, Tani M, Otake-Kasamoto Y, Uema R, Kato M, Tsujii Y, Inoue T, Yamada T, Kitamura T, Yonezawa A, Iijima H, Hayashi Y, Takehara T. Amano T, et al. Among authors: tani m. Sci Rep. 2024 Nov 29;14(1):29755. doi: 10.1038/s41598-024-80285-6. Sci Rep. 2024. PMID: 39613813 Free PMC article.
Dexamethasone is associated with reduced frequency and intensity of cytokine release syndrome compared with alternative corticosteroid regimens as premedication for glofitamab in patients with relapsed / refractory large B-cell lymphoma.
Falchi L, Hutchings M, Carlo-Stella C, Morschhauser F, Dickinson M, Cartron G, Khan C, Tani M, Martinez-Lopez J, Bartlett NL, Salar A, Brody JD, Leppä S, Berthier A, Kallemeijn M, Relf J, Tchaleu FB, Lundberg L, Bachy E. Falchi L, et al. Among authors: tani m. Haematologica. 2024 Nov 28. doi: 10.3324/haematol.2024.286257. Online ahead of print. Haematologica. 2024. PMID: 39605203 Free article.
1,366 results